Skip to content

Evaluation of Remineralization Potential of Self Assembling Peptide Combined With Fluoride

Evaluation of Remineralization Potential of Self Assembling Peptide P11-4 Combined With Fluoride Compared to Fluoride Varnish in Management of Incipient Carious Lesions Using Laser Fluorescence: Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05094492
Enrollment
58
Registered
2021-10-26
Start date
2021-10-30
Completion date
2022-06-30
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caries; Initial

Brief summary

Self-assembling peptide (P11-4) exhibited an outstanding ability for biomimetic re-mineralization of incipient enamel carious lesions. It creates a 3D matrix within the subsurface of carious lesions, allowing de novo formation of Hydroxyapatite crystals, thus enabling guided enamel regeneration of the demineralized enamel structure. Addition of fluoride to P11-4 may have a synergistic effect on the remineralization potential.

Detailed description

This study is a randomized clinical trial, with parallel study design, 1:1 allocation ratio and superiority framework. The aim of the current trial is to evaluate remineralization potential of P11-4 combined with fluoride compared to fluoride varnish in management of incipient white spot carious lesions. Progress of the lesions will be assessed using laser fluorescence (DIAGNOdent).

Interventions

OTHERBifluorid 10 fluoride varnish

5% Sodium Fluoride varnish (equal to 22,600 ppm fluoride)

P11-4 self assembling peptide combined with fluoride

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Active carious white spot lesions. * Patient compliance. * Controlled oral hygiene condition.

Exclusion criteria

* Participant in another trial. * Non carious lesions. * Systemic diseases or concomitant medication affecting salivary flow. * Cavitation of carious lesions. * Parafunctional habits. * Pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Remineralization6 monthsmeasuring carious lesion development using DIAGNOdent laser fluorescence (scores from 0 to 99) according to progression of the carious lesion

Countries

Egypt

Contacts

Primary ContactOmar O Shaalan, PhD
omar.shaalan@dentistry.cu.edu.eg00201122665661

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026